Widening Georgia's Science Network

After a decade of research collaboration, the Atlanta Clinical and Translational Science Institute will now be known as the Georgia Clinical and Translational Science Alliance (Georgia CTSA), reflecting a new statewide focus.

This alliance is expanding across the state through a-five-year, $51 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). The Emory-led Georgia CTSA will focus on transforming the quality and value of clinical research and translating research results into better outcomes for patients.

The Georgia CTSA unites the strengths of its academic partners—Emory, Morehouse School of Medicine, Georgia Tech, and most recently, the University of Georgia (UGA).

“Continuing such an alliance and involving these leading state institutions is extremely important and in line with Georgia’s goals for the promotion of clinical and translational research, innovation, and development,” says Georgia Goveror Nathan Deal. “Having an active Clinical and Translational Science Awardee in Georgia has brought our citizens cutting-edge cures and the latest in clinical and translational research.”

Georgia CTSA is one of sixty-four Clinical and Translational Science Awards at major academic medical centers across the country, funded by the NIH’s National Center for Advancing Translational Science, and the only one in Georgia. The award will fund cores focused on improving quality, efficiency, and collaboration of the research process; provide consultative support and new tools in bioinformatics and biostatistics; pilot funding for new research projects, training, and workforce development; while integrating special populations and focusing on participant interactions; and creating local centers tackling clinical trial inefficiencies.

“The Georgia CTSA creates a unique opportunity for synergy among historic partners in health care, education and cutting-edge research, and has emerged as an innovative and integrated environment where clinical and translational researchers can flourish,” says Robert Taylor, Georgia CTSA principal investigator for Emory.

Email the editor